GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » Financial Strength

Epsilon Healthcare (ASX:EPN) Financial Strength : 0 (As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare Financial Strength?

Epsilon Healthcare has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Epsilon Healthcare did not have earnings to cover the interest expense. Epsilon Healthcare's debt to revenue ratio for the quarter that ended in Jun. 2023 was 0.42. As of today, Epsilon Healthcare's Altman Z-Score is -4.89.


Competitive Comparison of Epsilon Healthcare's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epsilon Healthcare's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Financial Strength distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's Financial Strength falls into.



Epsilon Healthcare Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Epsilon Healthcare's Interest Expense for the months ended in Jun. 2023 was A$-0.03 Mil. Its Operating Income for the months ended in Jun. 2023 was A$-0.68 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was A$0.30 Mil.

Epsilon Healthcare's Interest Coverage for the quarter that ended in Jun. 2023 is

Epsilon Healthcare did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Epsilon Healthcare's Debt to Revenue Ratio for the quarter that ended in Jun. 2023 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2023 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.485 + 0.296) / 6.622
=0.42

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Epsilon Healthcare has a Z-score of -4.89, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of -4.89 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epsilon Healthcare  (ASX:EPN) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Epsilon Healthcare has the Financial Strength Rank of 0.


Epsilon Healthcare Financial Strength Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Epsilon Healthcare (ASX:EPN) Business Description

Traded in Other Exchanges
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (ASX:EPN) Headlines

No Headlines